ASK REDCHAT ANYTHING ABOUT QUOIN PHARMACEUTICALS LTD.
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX)
Listen to this Section
$3.77
+0.5200
(
+16.00% )
8.1M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| QRX003DetailsNetherton syndrome |
Phase 3 |
| QRX003DetailsSkin disease/disorder, Rare genetic disease, Peeling skin syndrome |
Phase 1 |
Market Data
|
| Open |
$3.77 |
| Previous Close |
$3.25 |
| Volume |
8.1M |
| Market Cap |
$6.53M |
| Day Range |
$3.64 - $5.80 |
| 52 Week Range |
$3.25 - $41.80 |
| Shares Outstanding |
2.01M |
| Change % |
+16.00% |
| Net Change |
▲ 0.5200 |
| Insider Ownership |
-0.03% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Medical/Dental Instruments |
| IPO Year | 2021 |
| Country | Israel |
Insider Ownership Transactions
Total Amount Purchased:
1,100,326.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-10-15 |
Buy |
15152.00 |
LANGER DENNIS |
| 2024-12-27 |
Buy |
555556.00 |
Myers Michael |
| 2024-12-27 |
Buy |
100000.00 |
Culverwell Anthony James |
| 2024-12-27 |
Buy |
122221.00 |
Dunn Gordon |
| 2024-12-27 |
Buy |
555556.00 |
Carter Denise P. |
| 2024-09-11 |
Buy |
856.00 |
Dunn Gordon |
| 2024-09-05 |
Buy |
800.00 |
Myers Michael |
| 2024-09-05 |
Buy |
1822.00 |
Carter Denise P. |
| 2024-06-10 |
Sale |
-297.00 |
LANGER DENNIS |
| 2023-10-30 |
Sale |
-51149.00 |
Dunn Gordon |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
13 |
Nov 12, 2025 |
| 10-q |
Quarterly Reports |
74 |
Nov 06, 2025 |
| 8-k |
8K-related |
13 |
Nov 06, 2025 |
| 8-k |
8K-related |
13 |
Oct 21, 2025 |
| 8-k |
8K-related |
20 |
Oct 15, 2025 |
| 4 |
Insider transactions |
1 |
Oct 15, 2025 |
| 3 |
Insider transactions |
2 |
Sep 08, 2025 |
| 8-k |
8K-related |
13 |
Aug 27, 2025 |
| 4 |
Insider transactions |
1 |
Aug 25, 2025 |
| 4 |
Insider transactions |
1 |
Aug 25, 2025 |